Latest News

        Sydney, Australia, 12th May 2022 - ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pan-antiviral prophylaxis in at-risk populations and...

  UniSuper, the $106 billion fund now open to all Australians, has today announced it has secured an investment relationship with Australia’s longest-established early-stage commercialisation fund manager - Uniseed   24 March 2022 - Uniseed, like UniSuper,...

      -- ENA Respiratory begins influenza challenge study for fast-acting nasal spray INNA-051, designed to boost innate immunity in patients at high risk of severe complications from respiratory infections Sydney, Australia, 16 March 2022 – Uniseed...

      Schneider Electric the leader in the digital transformation of energy management and automation has acquired Aurtra Pty Ltd The acquisition will position Aurtra’s cost-effective online transformer condition monitoring for transformer assets in the...

  Brisbane, Australia – March 7, 2022 – Aurora Solar Technologies Inc. announced plans to acquire Uniseed investee BT Imaging Pty Ltd, a well-established leader in photoluminescence (PL) imaging tools for PV material inspection and quality control during...

-- INNA-051 is being developed to stimulate innate immunity and reduce the incidence and severity of respiratory viral infections, such as COVID-19, rhinovirus, or influenza in populations at-risk of complications that include individuals with COPD. Sydney, Australia,...

    Melbourne, Australia – November 30, 2021 – Uniseed investee Q-Sera Pty Ltd, an Australian venture-backed company, announced today a partnership with Terumo Corporation, the leading Japanese medical device company, which will see its patent protected...

Natasha Rawlings, the Uniseed Investment Manager for Sydney, sat down with Sidney Macdessi of CRIISP Media to discuss what researchers and founders can do to make the most of an initial conversation with an investor, and how talking to potential customers is your...

    Inventor Associate Professor Michael Bowen, of the Uniseed investee Kinoxis Therapeutics, has been awarded the Prime Minister's Prize for New Innovators for his discovery and development of KNX100, a novel molecule that is being commercialised to treat...

    Uniseed investee LM+, as part of a global collaboration led by researchers from UNSW, has shown how liquid gallium can be used to help achieve the important goal of net zero carbon emissions. Engineers from UNSW have helped to discover a cheap new way to...